1. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK
2. Department of Nuclear Medicine, Ludwig-Maximilian University, Munich, Germany
3. Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, UK
4. GlaxoSmithKline, GSK Ltd. Clinical Unit, Cambridge, UK